Cancer patients show impaired immune responses, specifically in phytohemagglutinin (PHA) lymphocyte stimulation and E-rosette forming cells (E RFC) counts, before treatment. These immune markers can help monitor cancer patient competence.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: